您現在的位置 :

醫療團隊

專業的醫護人員，提供最佳的醫療服務

醫師介紹

  •

黃瓊慧醫師

糖尿病衛教及臨床流行病學、甲狀腺疾病、糖尿病、代謝症候群、內分泌疾病、糖尿病足病變
  • 國語,英語,閩南語
  • 助理教授
醫師網路掛號
直接點選進入醫師網路掛號畫面
醫師資歷
  • 現職
    • 助理教授級主治醫師
  • 學歷
    • 台北醫學大學醫學系
  • 經歷
    • 林口長庚醫院內分泌暨新陳代謝科講師級主治醫師
    • 林口長庚醫院內分泌暨新陳代謝科住院醫師
  • 學會與認證
    • 中華民國內科學會專科會員
    • 中華民國內分泌與糖尿病學會會員
  • 論文及期刊發表
    • Are current wound classifications valid for predicting prognosis in people treated for limb-threatening diabetic foot ulcers?
      Int Wound J. 2023; 1-9. DOI: 10.1111/iwj14338.
      Chang YC, Huang YY, Hung SY, Yeh JT, Lin CW, Chen IW, Wei HH, Yang HM, Huang CH*.
    • Diabetic foot disease in subjects with End-stage renal Disease: A nationwide study over 14 years highlighting an emerging threat.
      Diabetes Res Clin Pract 2022; 193:110134.
      Lin CH, Armstrong DG, Huang CH, Lin CH, Hung SY, Liu PH, Huang YY.
    • Survival of patients following first diagnosis of diabetic foot complications: A nationwide 15-year longitudinal analysis.
      Frontiers in Endocrinology. 2021 DOI:10.3389/fendo.2021.801324.
      Lin CH, Armstrong DG, Liu PH, Lin CW, Huang CH, Huang YY*.
    • A comprehensive investigation of nutritional status and psoas muscle mass in predicting five-year survival in patients with liver transplant.
      J Formos Med Assoc 2021; S0929-6646(21)00461-7.
      Tsao YZ, Lee WC, Huang CH, Lin IH, Huang YY*.
    • Impact of wound microbiology on limb preservation in patients with diabetic foot infection.
      J Diabetes Invest 2021; doi: 10.1111/jdi.13649.
      Hung SY, Chiu CH, Huang CH, Lin CW, Yeh JT, Yang HM, Huang YY*.
    • Modifiable factors related to 7-year renal outcomes in subjects with type 2 diabetes and chronic kidney disease stage 3.
      Journal of Postgraduate Medicine 2020; 66(4): 187-193.
      Huang CH, Chen CP, Huang YY, Hsu BRS*.
    • Amino acids and wound healing in people with limb-threatening diabetic foot ulcers.
      J of Diabetes and its Complications 2019; 33: 107403.
      Hung SY, Tsai JS, Yeh JT, Chen KH, Lin CN, Yang HM, Lin CW, Chen HY, Huang CH, Huang YY*.
    • Diabetic Foot Infection presenting systemic inflammatory response syndrome: A unique disorder of systemic reaction from infection of the most distal body.
      Journal of Clinical Medicine 2019; 8(10): 1538.
      Lin CW, Hung SY, Huang CH, Yeh JT, Huang YY*.
    • Nationwide trends in the epidemiology of diabetic foot complications and lower-extremity amputation over an 8-year period.
      BMJ Open Diabetes Research & Care 2019; 7: e000795.
      Lin CW, Armstrong DG, Lin CH, Liu PH, Hung SY, Lee SR, Huang CH, Huang YY*.
    • The efficacy and safety of concentrated herbal extract granules, YH1, as an add-on medication in poorly controlled type 2 diabetes: a randomized, double-blind, placebo-controlled pilot trial.
      PloS one, 2019, 14.8: e0221199.
      Huang YH, Chen ST, Liu FH, Hsieh SH, Lin CH, Liou MJ, Wang CC, Huang CH, Liu GH, Lin JR, Yang LY, Hsu TY, Lee MC, Huang CT, Wu YH*.
    • Antimicrobial resistance and outcomes of community-onset bacterial bloodstream infections in patients with type 2 diabetes.
      J of Global Antimicrobial Resistance 2018; 15: 271-276.
      Huang CH, Chiu CH, Chen IW, Hung SY, Lin CW, Hsu BRS, Huang YY*.
    • A short-term follow-up of glycemic and body weight changes in diabetic patients who replaced dipeptidyl peptidase-4 inhibitors with the sodium-glucose cotransporter 2 inhibitor empagliflozin.
      Ann Saudi Med 2018; 38: 420-426.
      Huang CH, Huang YY, Hsu BRS*.